{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:40:05Z","timestamp":1768084805633,"version":"3.49.0"},"reference-count":161,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2406,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1600-0404.1985.tb00854.x","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T18:37:06Z","timestamp":1279996626000},"page":"129-139","source":"Crossref","is-referenced-by-count":66,"title":["Valproate: an updated review"],"prefix":"10.1155","volume":"72","author":[{"given":"L.","family":"Gram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Drachmann","family":"Bentsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1528-1157.1975.tb04738.x","article-title":"Sodium Di-N-propylacetate (DPA) in the treatment of epilepsy. A review","volume":"16","author":"Simon","year":"1975","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197713020-00001","article-title":"Sodium valproate: A review of its pharmacological properties and therapeutic efficacy in epilepsy","volume":"13","author":"Pinder","year":"1977","journal-title":"Drugs"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.1978.03290200068031","article-title":"Valproic acid (Deprakene). A new anticonvulsant drug","volume":"240","author":"Lewis","year":"1978","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archneur.1979.00500430023002","article-title":"Valproic acid. Review of a new antiepileptic drug","volume":"36","author":"Bruni","year":"1979","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM198003203021204","article-title":"Valproic acid","volume":"302","author":"Koch-Weser","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB6|cit6","unstructured":"The place of sodium valproate in the treatment of epilepsy Royal Society of Medicine 1979"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB7|cit7","volume-title":"Valproate in the treatment of seizures","year":"1981"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB8|cit8","unstructured":"Third international symposium on sodium valproate Brit J Clin Pract 1983 Symp suppl 27"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB9|cit9","doi-asserted-by":"crossref","unstructured":"Valproate modern perspectives Epilepsia 1984 25 suppl 1","DOI":"10.1111\/j.1528-1157.1984.tb05642.x"},{"issue":"suppl 2","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0361-9230(80)90094-5","article-title":"Mechanism of action of valproate","author":"Meldrum","year":"1980","journal-title":"Brain Res Bull"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-6147(80)90014-0","article-title":"Sodium valproate, GABA and epilepsy","volume":"1","author":"Turner","year":"1980","journal-title":"Trends Pharm Sci"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB12|cit12","first-page":"21","article-title":"The mechanism of action of sodium valproate","volume":"12","author":"Kerwin","year":"1981","journal-title":"Gen Pharmac"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0301-0082(82)90010-7","article-title":"Mechanism of action of valproate","volume":"19","author":"Chapman","year":"1982","journal-title":"Prog Neurobiol"},{"issue":"suppl 1","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1984.tb05630.x","article-title":"Valproic acid: Update on its mechanism of action","volume":"25","author":"Johnston","year":"1984","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0006-2952(76)90343-9","article-title":"Anti-convulsant action of ethanolamine-0-sulfate and din-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures","volume":"25","author":"Anlezark","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1476-5381.1980.tb10971.x","article-title":"The effect of Sodium-n-di-propylacetate on \u03b1-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity","volume":"71","author":"Kerwin","year":"1980","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB17|cit17","first-page":"159","volume-title":"Problems in GABA research from brain to bacteria","author":"Gale","year":"1982"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0006-8993(79)90975-2","article-title":"Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neurous","volume":"170","author":"McDonald","year":"1979","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(80)90459-X","article-title":"Sodium di-n-propylacetate (valproate) potential responses to GABA and muscinol on single central neurons","volume":"197","author":"Gent","year":"1980","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-8993(82)90971-4","article-title":"Sodium valproate enhances responses to GABA receptor activation only at high concentrations","volume":"250","author":"Harrison","year":"1982","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1528-1157.1978.tb04504.x","article-title":"Sodium valproate increases potassium conductance in Aplysia neurous","volume":"19","author":"Slater","year":"1978","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(81)91217-8","article-title":"The presynaptic effects of valproic acid in the isolated frog spinal cord","volume":"220","author":"Hackman","year":"1981","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1471-4159.1978.tb06258.x","article-title":"Effect of n-dipropylacetate on amino acid concentrations in mouse brain: Correlation with anti-convulsant activity","volume":"31","author":"Schechter","year":"1978","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003495-198427040-00003","article-title":"Anticonvulsant drugs. An update","volume":"27","author":"Eadie","year":"1984","journal-title":"Drugs"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-198403000-00001","article-title":"The clinical pharmacology of antiepileptic drugs","volume":"7","author":"Bruni","year":"1984","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/cpt1977216736","article-title":"Pharmacokinetics and bio-availability of sodium valproate","volume":"21","author":"Klotz","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2125.1978.tb01652.x","article-title":"Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease","volume":"5","author":"Gugler","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1528-1157.1979.tb04808.x","article-title":"Sodium Valproate, serum level and clinical effect in epilepsy: A controlled study","volume":"20","author":"Gram","year":"1979","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2125.1978.tb01663.x","article-title":"Disposition of sodium valproate in epileptic patients","volume":"5","author":"Perucca","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1528-1157.1981.tb06154.x","article-title":"Reduction of stady-state velproate levels by other anti-epileptic drugs","volume":"22","author":"Sackellares","year":"1981","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1984.tb02482.x","article-title":"A comparative study of the relative endogene inducing properties of anticonvulsant drugs in epileptic patients","volume":"18","author":"Perucca","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB32|cit32","first-page":"158","article-title":"Anticonvulsant activity of metabolites of valproic acid","volume":"249","author":"L\u00f6scher","year":"1981","journal-title":"Arch Int Pharmacodyn"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB33|cit33","first-page":"317","article-title":"Pharmakokinetic study of valproic acid in a neonate","volume":"2","author":"Irvine-Meek","year":"1982","journal-title":"Pediat Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2125.1984.tb02401.x","article-title":"Pharmacokinetics of valproic acid in the elderly","volume":"17","author":"Perucca","year":"1984","journal-title":"Brit J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2165\/00003088-198207060-00003","article-title":"Anticonvulsants during pregnancy and lactation: Transplacental, maternal and neonatal pharmacokinetics","volume":"7","author":"Nau","year":"1982","journal-title":"Clin Pharmacokin"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007691-198001000-00008","article-title":"Therapeutic monitoring of valproic acid","volume":"2","author":"Schobben","year":"1980","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00007691-198004000-00015","article-title":"Monitoring of free valproic acid levels","volume":"2","author":"Levy","year":"1980","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2165\/00003495-198224060-00004","article-title":"Drug interactions with valproic acid","volume":"24","author":"Levy","year":"1982","journal-title":"Drugs"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2125.1982.tb01421.x","article-title":"Valproic acid and diazepam interaction vivo","volume":"13","author":"Dhillon","year":"1982","journal-title":"Brit J Clin Pharmacol"},{"issue":"suppl 1","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1528-1157.1984.tb05633.x","article-title":"Open trials with valproate in epilepsy","volume":"25","author":"Dulac","year":"1984","journal-title":"Epilepsia"},{"issue":"suppl 1","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1528-1157.1984.tb05634.x","article-title":"Controlled and comparative trials of valproate performed in Europe and Asia","volume":"25","author":"Gram","year":"1984","journal-title":"Epilepsia"},{"issue":"suppl 1","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1528-1157.1984.tb05635.x","article-title":"Controlled and comparative trials with valproate: United States","volume":"25","author":"Ramsay","year":"1984","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1469-8749.1981.tb02018.x","article-title":"Treatment of infantile spasms with sodium dipropylacetic acid","volume":"23","author":"Pavone","year":"1981","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archneur.1982.00510130051013","article-title":"Use of valproic acid in treatment of infantile spasms","volume":"39","author":"Bachman","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB45|cit45","first-page":"713","article-title":"Doppeltblind Untersuchung \u00fcber die anticonvulsive Wirkung von Phenobarbital und Valproat beim Lennox-syndrome","volume":"108","author":"Vasella","year":"1978","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1528-1157.1982.tb05085.x","article-title":"Sodium valproate: Monotherapy and polytherapy","volume":"23","author":"Covanis","year":"1983","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1982.03970420050011","article-title":"Valproic acid in the treatment of intractable absence seizures in children","volume":"136","author":"Erenberg","year":"1982","journal-title":"Am J Dis Child"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB48|cit48","first-page":"470","article-title":"A double-blind comparative trial of sodium dipropylacetate and ethosuximide in epilepsy in children with special emphasis on pure petit mal seizures","volume":"52","author":"Suzuki","year":"1972","journal-title":"Med Prog"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1469-8749.1982.tb13703.x","article-title":"Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)","volume":"24","author":"Callaghan","year":"1982","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1212\/WNL.32.2.157","article-title":"Valproic acid versus ethosuximide in the treatment of absence seizures","volume":"32","author":"Sato","year":"1982","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archneur.1983.04050120047006","article-title":"Valproate-ethosuximide combination therapy for refractory absence seizures","volume":"40","author":"Rowan","year":"1983","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bmj.4.5991.255","article-title":"Controlled trial of sodium valproate in severe epilepsy","volume":"4","author":"Richens","year":"1975","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1528-1157.1977.tb04462.x","article-title":"Valproate sodium: A controlled trial including monitoring of serum levels","volume":"18","author":"Gram","year":"1977","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1981.tb04330.x","article-title":"Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy","volume":"22","author":"Shakir","year":"1981","journal-title":"Epilepsia"},{"issue":"Symp suppl 27","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB55|cit55","first-page":"3","article-title":"A comparison of phenytoin and valproate in previously untreated adult epileptic patients","author":"Turnbull","year":"1983","journal-title":"Brit J Clin Pract"},{"issue":"Symp suppl 27","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB56|cit56","first-page":"7","article-title":"A comparative study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy: A preliminary communication","author":"Callaghan","year":"1983","journal-title":"Brit J Clin Pract"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/WNL.33.11.1474","article-title":"Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures","volume":"33","author":"Wilder","year":"1983","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB58|cit58","unstructured":"Shakir R A Sodium valproate, phenytoin and carbamazepine as sole anticonvulsants The place of sodium valproate in the treatment of epilepsy 1979 7 16"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB59|cit59","first-page":"434","article-title":"Efficacit\u00e9 du valproate de sodium dans les \u00e9pilepsies partielles","volume":"140","author":"Loiseau","year":"1984","journal-title":"Rev Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archneur.1983.04050030029004","article-title":"Valproic acid therapy for complex partial seizures","volume":"40","author":"Bruni","year":"1983","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1528-1157.1976.tb04459.x","article-title":"Valproic acid; reversibly acting drugs","volume":"17","author":"Lockard","year":"1976","journal-title":"Epilepsy"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1157.1979.tb04776.x","article-title":"The delayed effect of sodium valproate in man","volume":"20","author":"Rowan","year":"1979","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.1980.tb04328.x","article-title":"Once-daily sodium valproate in the treatment of epilepsy","volume":"22","author":"Covanis","year":"1980","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB64|cit64","first-page":"527","volume-title":"Advances in epileptology. Proceedings of the XII Epilepsy International Symposium","author":"Covanis","year":"1981"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB65|cit65","first-page":"533","volume-title":"Advances in epileptology. Proceedings of the XII Epilepsy International Symposium","author":"Rowan","year":"1981"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1528-1157.1984.tb04171.x","article-title":"Intensive follow-up monitoring in patients with once daily evening adminstration of sodium valproate","volume":"25","author":"Stefan","year":"1984","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0404.1984.tb07788.x","article-title":"Monodose versus 3 daily doses of sodium valproate: A controlled trial","volume":"69","author":"Gjerl\u00f8ff","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1528-1157.1975.tb04746.x","article-title":"Prevention of febrile convulsions with dipropylacetate (DepakineR)","volume":"16","author":"Cavazutti","year":"1975","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/adc.55.3.171","article-title":"Continous sodium valproate or phenobarbitone in the prevention of \u201csimple\u201d febrile convulsions","volume":"55","author":"Ngwane","year":"1980","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bmj.280.6211.353","article-title":"Successful prophylaxis against febrile convulsions with valproic acid or phenobarbitone","volume":"1","author":"Wallace","year":"1980","journal-title":"Br Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00441308","article-title":"Sodium valproate versus phenobarbital in the prophylactic treatment of febrile convulsions in childhood","volume":"37","author":"Lee","year":"1981","journal-title":"Europ J Pediatr"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2008-1052338","article-title":"Prevention of recurrent febrile convulsions - A randomised therapeutic assay: Sodium valproate, phenobarbital and placebo","volume":"15","author":"Mamelle","year":"1984","journal-title":"Neuropediatrics"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0387-7604(81)80067-8","article-title":"Phenobarbital, primidone and sodium valproate in the prophylaxis of febrile convulsions","volume":"3","author":"Minagawa","year":"1981","journal-title":"Brain Dev"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1528-1157.1984.tb04160.x","article-title":"Effectiveness and toxicity of phenobarbital, primidone and sodium valproate in the prevention of febrile convulsions, controlled by plasma levels","volume":"25","author":"Herranz","year":"1984","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/000992287901800710","article-title":"Sodium valproate in the prophylaxis of simple febrile convulsions","volume":"18","author":"Williams","year":"1979","journal-title":"Clin Pediatr"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1528-1157.1982.tb05437.x","article-title":"Controlled trials in epilepsy: A review","volume":"23","author":"Gram","year":"1982","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/bmj.3.5934.808-a","article-title":"Treatment of status epilepticus with sodium valproate","volume":"3","author":"Manhire","year":"1974","journal-title":"Brit Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1469-8749.1976.tb03634.x","article-title":"The use of sodium valproate in a case of status epilepticus","volume":"18","author":"Barnes","year":"1976","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.30.10.1113","article-title":"Rectal valproate syrup and status epilepticus","volume":"30","author":"Thorpy","year":"1980","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.28.9.897","article-title":"Rectal administration of sodium valproate in status epilepticus","volume":"28","author":"Vajda","year":"1978","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00625806","article-title":"Absorption rate and biovailability of valproic acid and its sodium salt from rectal dosage forms","volume":"17","author":"Molenaar","year":"1980","journal-title":"Europ J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/WNL.26.1.61","article-title":"Huntington's chorea: Treatment with di-propylacetate and GABA","volume":"26","author":"Shoulson","year":"1976","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/archneur.1977.00500170062012","article-title":"Valproate sodium and Huntington's chorea","volume":"34","author":"Pearce","year":"1977","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1212\/WNL.27.2.193","article-title":"Long-term treatment of juvenile Huntington's chorea with dipropylacetic acid","volume":"27","author":"Bachmann","year":"1977","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0317167100023970","article-title":"Treatment of Parkinson's disease with sodium valproate: Clinical, pharmacological and biochemical observations","volume":"6","author":"Nutt","year":"1979","journal-title":"Can J Neurol Sci"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jnnp.41.8.702","article-title":"Sodium valproate in the treatment of levodopa-induced dyskinesia","volume":"41","author":"Price","year":"1978","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1192\/bjp.129.2.114","article-title":"Effect of sodium valproate on tardive dyskinesias","volume":"129","author":"Linnoila","year":"1976","journal-title":"Brit J Psychiat"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1017\/S031716710002388X","article-title":"Sodium valproate in the treatment of cerebellar disorders","volume":"6","author":"Neophytides","year":"1979","journal-title":"Can J Neurol Sci"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5694\/j.1326-5377.1980.tb131854.x","article-title":"Sodium valproate in trigeminal neuralgia","volume":"2","author":"Peiris","year":"1980","journal-title":"Med J Aust"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/WNL.31.11.1458","article-title":"Treatment of intractable hiccups with valproic acid","volume":"31","author":"Jacobson","year":"1981","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.283.6283.17","article-title":"Hemiballismus treated with sodium valproate","volume":"283","author":"Lenton","year":"1981","journal-title":"Brit Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bmj.283.6286.274","article-title":"Valproic acid in Sydenham's chorea","volume":"283","author":"McLachlan","year":"1981","journal-title":"Brit Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1212\/WNL.31.9.1162","article-title":"Improvement of stiff-man syndrome with sodium valproate","volume":"31","author":"Spehlmann","year":"1981","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bmj.285.6345.853","article-title":"Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopatic orofacial dystonia)","volume":"285","author":"Brennan","year":"1982","journal-title":"Brit Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(81)92349-7","article-title":"Effect of treatment with sodium valproate and diazepam on plasma corticotrophin in Nelson's syndrome","volume":"2","author":"Jones","year":"1981","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1981.tb00649.x","article-title":"Effect of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and Cushing's disease","volume":"15","author":"Elias","year":"1981","journal-title":"Clin Endocinol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB97|cit97","first-page":"61","volume-title":"Clinical and pharmacological aspects of sodium valproate (Epilim) in the treatment of epilepsy","author":"Noronha","year":"1976"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0404.1979.tb02959.x","article-title":"Side effects of sodium valproate during long-term treatment of epilepsy","volume":"60","author":"Ruuskanen","year":"1979","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB99|cit99","first-page":"65","volume-title":"Valproate in the treatment of seizures","author":"Gram","year":"1981"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB100|cit100","first-page":"141","volume-title":"The place of sodium valproate in the treatment of epilepsy, Royal Society of Medicine","author":"Laljee","year":"1980"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.30.1.31","article-title":"Treatment of childhood epilepsy with valproic acid: Results of the first 100 patients in a 6-months trial","volume":"30","author":"Sherard","year":"1980","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(77)91154-0","article-title":"Valproate and curly hair","volume":"1","author":"Jeavons","year":"1977","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1469-8749.1981.tb02473.x","article-title":"Change in hair colour induced by valproic acid","volume":"23","author":"Herranz","year":"1981","journal-title":"Dev Child Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.283.6291.577","article-title":"Effects of sodium valproate in 100 children with special reference to weight","volume":"283","author":"Egger","year":"1981","journal-title":"Brit Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0404.1984.tb00804.x","article-title":"Weight gain during treatment with valproate","volume":"70","author":"Dinesen","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0404.1983.tb04569.x","article-title":"Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate","volume":"67","author":"Bentsen","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1528-1157.1981.tb04094.x","article-title":"Sodium valproate, platelet dysfunction and bleeding","volume":"22","author":"Loiseau","year":"1981","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/adc.57.9.681","article-title":"Valproic acid and immune thrombocytopenia","volume":"57","author":"Barr","year":"1982","journal-title":"Arch Dis Childh"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB109|cit109","first-page":"101","volume-title":"Chronic toxicity of antiepileptic drugs","author":"Rochel","year":"1983"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB110|cit110","first-page":"179","article-title":"Sodium valproate and platelet dysfunction","volume":"3","author":"Richardson","year":"1976","journal-title":"Brit Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1982.03320260037026","article-title":"Pure red cell aplasia associated with sodium valproate therapy","volume":"247","author":"McDougall","year":"1982","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.410080213","article-title":"Sodium valproate and bone marrow-suppression","volume":"8","author":"Smith","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/WNL.29.8.1177","article-title":"Tremor due to sodium valproate","volume":"29","author":"Hyman","year":"1979","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1212\/WNL.32.4.428","article-title":"Valproate tremors","volume":"32","author":"Karas","year":"1982","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1212\/WNL.33.10.1380","article-title":"Treatment of valproate tremors","volume":"33","author":"Karas","year":"1983","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1212\/WNL.31.2.194","article-title":"Asterixis associated with sodium valproate","volume":"31","author":"Bodensteiner","year":"1981","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.2.5919.584","article-title":"Sodium valproate in treatment of epilepsy","volume":"2","author":"Jeavons","year":"1974","journal-title":"Brit Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB118|cit118","first-page":"40","volume-title":"Clinical and pharmalogical aspects of sodium valproate (Epilim) in the treatment of epilepsy","author":"Harwood","year":"1976"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1528-1157.1977.tb04463.x","article-title":"Clinical pharmacological aspects of valproate sodium","volume":"18","author":"Wulff","year":"1977","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB120|cit120","first-page":"366","volume-title":"Advances in epileptology","author":"Rai","year":"1978"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1528-1157.1979.tb04853.x","article-title":"Stupor following administration of valproic acid to patients receiving other antiepileptic drugs","volume":"20","author":"Sackellares","year":"1979","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1157.1982.tb06195.x","article-title":"Stuporous episodes during treatment with sodium valproate: Report of seven cases","volume":"23","author":"Marescaux","year":"1982","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0016-5085(81)90148-7","article-title":"Recurrent pancreatitis induced by valproic acid. A case report and review of the literature","volume":"80","author":"Parker","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(81)90143-4","article-title":"Valproic acid associated pancreatitis in an adult","volume":"1","author":"Murphy","year":"1981","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(80)91660-8","article-title":"Pancreatitis due to valproic acid","volume":"1","author":"Sasaki","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5694\/j.1326-5377.1982.tb132476.x","article-title":"Acute pancreatitis and sodium valproate","volume":"2","author":"Ng","year":"1982","journal-title":"Med J Aust"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB127|cit127","first-page":"912","article-title":"Pancreatitits associated with valproate therapy","volume":"138","author":"Wyllie","year":"1984","journal-title":"Amer J Dis Child"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ana.410070118","article-title":"Pancreatitis associated with valproic acid therapy for epilepsy","volume":"7","author":"Coulter","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: Analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gut.25.6.673","article-title":"Hepatic toxicity of sodium valproate: A review","volume":"25","author":"Powell-Jackson","year":"1984","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1157.1984.tb05638.x","article-title":"Non-dose-related side effects of valproate","volume":"25","author":"Jeavons","year":"1984","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.1840020520","article-title":"Sodium valproate in the induction of unusual hepatotoxicity","volume":"2","author":"Zafrani","year":"1982","journal-title":"Hepatology"},{"issue":"suppl 97","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1983.tb01537.x","article-title":"Hepatic toxicity of antiepileptic drugs: A review","volume":"68","author":"Gram","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jama.1979.03300110045025","article-title":"A direct hepatotoxic effect of valproic acid","volume":"242","author":"Sussman","year":"1979","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB135|cit135","first-page":"961","volume":"28","author":"Willmore","year":"1978","journal-title":"Effect of valproic acid on hepatic function"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB136|cit136","first-page":"875","article-title":"Sodium valproate-induced liver injury","volume":"77","author":"Itoh","year":"1982","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(63)90554-3","article-title":"Encephalopathy and fatty acid degeneration of the viscera: A disease entity in childhood","volume":"2","author":"Reye","year":"1963","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0031-6997(25)06873-5","article-title":"Hypoglycin and hypoglycin-like compounds","volume":"21","author":"Bressler","year":"1969","journal-title":"Pharmacol Rev"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB139|cit139","first-page":"30","article-title":"Abnormal metabolism of valproic acid in fatal hepatic failure","volume":"141","author":"Kochen","year":"1983","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(80)90197-X","article-title":"Inhibition of fatty acid oxidation by valproate","volume":"2","author":"Mortensen","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1600-0404.1982.tb06862.x","article-title":"Two cases of reversible liver lesion induced by valproate","volume":"66","author":"Thygesen","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB142|cit142","first-page":"642","article-title":"Epilepsy and IgA deficiency - the effect of sodium valproate","volume":"52","author":"Joubert","year":"1977","journal-title":"S Afr Med J"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB143|cit143","first-page":"115","article-title":"The influence of chronic N-dipropyl-acetamide \u201cDepamide\u201d treatment on plasmatic immunoglobulins of epileptic patients","volume":"35","author":"Musolino","year":"1980","journal-title":"Acta Neurol (Napoli)"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1528-1157.1983.tb03428.x","article-title":"Sodium valproate associated with phenobarbital: Effect on ammonia metabolism in humans","volume":"24","author":"Warter","year":"1983","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/WNL.32.2.206","article-title":"Sodium valproate induced hyperammonemia without clinical hepatic dysfunction","volume":"32","author":"Zaret","year":"1982","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archneur.1982.00510210061016","article-title":"Asymptomatic hyperammonemia in patients receiving valproic acid","volume":"39","author":"Murphy","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1212\/WNL.34.4.550","article-title":"Valproic acid-induced hyperammonemia in mentally retarded adults","volume":"34","author":"Williams","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1528-1157.1980.tb04310.x","article-title":"Inhibition of the glycine cleavage system: Hyperglycinemia and hyperglycinuria caused by valproic acid","volume":"21","author":"Mortensen","year":"1980","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB149|cit149","first-page":"159","article-title":"Amenorrhea following initiation of therapy with valproic acid","volume":"31","author":"Margraf","year":"1981","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB150|cit150","first-page":"85","volume-title":"Chronic toxicity of antiepileptic drugs","author":"Fichel","year":"1983"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/WNL.34.10.1393","article-title":"Selenium, zinc and copper changes with valproic acid: Possible relation to drug side effects","volume":"34","author":"Hurd","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB152|cit152","first-page":"219","article-title":"Oral state of children with epilepsy on treatment with sodium valproate","volume":"91","author":"Eeg-Olofsson","year":"1983","journal-title":"Scand J Dent Res"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB153|cit153","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1528-1157.1984.tb05640.x","article-title":"Sodium valproate and cognitive function","volume":"25","author":"Trimble","year":"1984","journal-title":"Epilepsia"},{"issue":"suppl 99","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0404.1984.tb05665.x","article-title":"The influence of carbamazepine and phenytoin in new referrals with epilepsy","volume":"69","author":"Andrewes","year":"1984","journal-title":"Acta Neurol Scand"},{"issue":"suppl 94","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB155|cit155","first-page":"39","article-title":"Antiepileptic drugs and teratogenesis","volume":"67","author":"Friis","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","article-title":"Maternal valproic acid and congenital neural tube defects","volume":"2","author":"Robert","year":"1982","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB157|cit157","first-page":"1313","article-title":"Valproate and malformations","volume":"2","author":"Anonymous","year":"1982","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB158|cit158","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(82)90018-6","article-title":"Valproic acid and spina bifida","volume":"2","author":"Bjerkedal","year":"1982","journal-title":"Lancet"},{"issue":"suppl 94","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB159|cit159","first-page":"35","article-title":"Treatment of epilepsy in women of child-bearing age: Patients' opinion of teratogenic potential of valproate","volume":"67","author":"Philbert","year":"1983","journal-title":"Acta Neurol Scand"},{"issue":"Symp suppl 27","key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB160|cit160","first-page":"58","article-title":"Overdose with valproate","author":"Volans","year":"1983","journal-title":"Brit J Clin Pract"},{"key":"10.1111\/j.1600-0404.1985.tb00854.x-BIB161|cit161","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1528-1157.1984.tb04165.x","article-title":"Electroencephalographic alterations during intoxication with sodium valproate: A case report","volume":"25","author":"Pedersen","year":"1984","journal-title":"Epilepsia"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1985.tb00854.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1985.tb00854.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T09:46:11Z","timestamp":1740303971000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1985.tb00854.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":161,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1985.tb00854.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}